| Similar Articles |
|---|
 |
Chemistry World
October 2008
Rebecca Trager |
The winning chemistry As the US prepares for its presidential election, the author looks at where each candidate stands on science   |
Pharmaceutical Executive
April 1, 2011 |
Revisiting Reform Courts, Congress review policies and programs shaping drug costs and access. |
CIO
September 30, 2008
Grant Gross |
Where the Candidates Stand on Five Technology Issues The 2008 presidential election gives CIOs and other IT executives a choice of Republican nominee Senator John McCain and Democratic nominee Senator Barack Obama who are both interested in technology-related issues. |
InternetNews
October 20, 2008
Jeff Goldman |
Mr. Wi-Fi Goes to Washington? Obama's and McCain's policies regarding wireless technology and the Internet may not be front and center in media coverage of their campaigns, but their differences are worth a look. |
Pharmaceutical Executive
January 1, 2011
Jill Wechsler |
Politics & PDUFA Pharma companies will assess health reform, negotiate user fees and keep an eye on federal prosecutors in the year ahead. |
Pharmaceutical Executive
December 1, 2008
Jill Wechsler |
Challenge and Challenges Expanded healthcare coverage also fits the goals of pharma manufacturers. |
Pharmaceutical Executive
April 1, 2009
Jill Wechsler |
Kickoff for Reform In addition to overhauling healthcare, Congress is weighing proposals for updating FDA policies and expanding access to drugs. |
Chemistry World
March 25, 2010
Rebecca Trager |
Big pharma scores in US healthcare reform President Obama has signed the biggest US healthcare reform since the 1960s, and although it is largely seen as a victory for the pharmaceutical industry, some analysts are characterising it as a 'double-edged sword'. |
Pharmaceutical Executive
January 1, 2011 |
The Steep, Slow Climb A survey of leading experts reveals 2011's sobering reality and the trends that smart drugmakers will follow into the next decade. |
BusinessWeek
March 24, 2010
Nussbaum et al. |
Obamacare's Cost Scalpel How does the health-care overhaul propose to control spending? By evaluating treatments through "comparative effectiveness research" |
IndustryWeek
October 1, 2008
David Blanchard |
Taking Care of Business: The Great Debate Where do McCain and Obama stand on key manufacturing issues? |
InternetNews
September 5, 2008
Kenneth Corbin |
Obama up in Web Spend; McCain Surges in Video New analysis profiles two candidates' online ad campaigns, finding Obama more invested in the Web, though McCain might be reaching the voters who count. |
The Motley Fool
January 26, 2011
Brian Orelli |
Health-Care Reform Lives: Here's Where to Invest State of the Union turned investment thesis regarding health insurance companies. |
The Motley Fool
May 12, 2009
Brian Orelli |
Your Company Is Giving Away Revenue Bad news for investors in the health-care industry: the companies you invest in just pledged to give back 1.5% of their expected U.S. revenue growth to President Obama. |
Pharmaceutical Executive
January 1, 2009
Walter Armstrong |
Up in the Air If pharma execs start upping their consumption of antihypertensives and anxiolytics (all branded, of course) in the months to come, it won't be a huge surprise. The industry faces a truly unprecedented number of political and policy challenges. |
Pharmaceutical Executive
April 10, 2014 |
Obama Policies Reshape Pharma Marketing Health reform initiatives promote transparency, challenge reimbursement, writes Jill Wechsler. |
On Wall Street
October 1, 2011
Kevin Wack |
Big Banks Shift Campaign Cash Away from Obama In 2012 So far in the 2012 race, the six largest U.S. banks have switched sides in a dramatic way since 2008, giving far more money to GOP hopeful Mitt Romney than they are to the sitting president. |
BusinessWeek
June 19, 2008
Michael Mandel |
Job One for McCain or Obama: Jobs As Barack Obama and John McCain move into the next stage of the Presidential campaign, there's one economic question they won't be able to escape: What should Washington do to reverse the decline in manufacturing jobs? How each candidate answers that question might help decide which one wins. |
Pharmaceutical Executive
October 1, 2011 |
The Permanent Campaign The product launch has been transformed from a concentrated, all-out military assault to the subtle, persuasive art of electioneering. |
Pharmaceutical Executive
December 1, 2010
Jill Wechsler |
New Ballgame in Washington Republican gains in Congress create uncertainty for health reform, drug regulation, and biomedical research |
Chemistry World
August 29, 2012
Rebecca Trager |
Presidential candidates search for the right chemistry As the US prepares for a presidential election on 6 November, science and research groups appear to backing the current incumbent President Barack Obama. |
Pharmaceutical Executive
October 1, 2012
Ben Comer |
The Drug Vote 2012 A comparative effectiveness study on the two presidential candidates. |
Investment Advisor
October 2008
Melanie Waddell |
And the Winner Is... A refresher course on the Presidential candidates positions of importance to the financial services industry. |
The Motley Fool
February 12, 2009
Brian Orelli |
Stimulus Could Be Bitter Pill for Some Investors Health-care shareholders need to watch provisions of the stimulus bill closely. |
InternetNews
October 31, 2008
Kenneth Corbin |
Where Do McCain and Obama Stand on Tech? With four days to go until the election, do you know the candidates' stances on key IT issues? |
HBS Working Knowledge
November 12, 2008
John Quelch |
The Marketing of a President Barack Obama's run for the White House was a model of marketing excellence. Here's why it worked so well. |
The Motley Fool
November 7, 2008
Brian Orelli |
Will Obama Make Your Portfolio Healthy? The changes coming in the health-care industry could be a mixed bag of good and bad for your portfolio. |
Search Engine Watch
June 13, 2008
Chris Boggs |
SEO Baseline: U.S. Presidential Election 2008 Now that the Democrats have finally picked Barack Obama to run against Republican John McCain in the 2008 U.S. Presidential election, it's a good time to examine the two candidates' Web sites from a SEO perspective. |
The Motley Fool
November 30, 2010
Brian Orelli |
A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist. |
Pharmaceutical Executive
December 1, 2012
Jill Wechsler |
Obamacare, Innovation and Pricing Tax and budget decisions will shape the healthcare market and drug research and regulation. |
Pharmaceutical Executive
October 1, 2010 |
Taking a Less-Generic Route to Generics A leading pharmaceutical industry player speaks out on what is fueling success in the sector. |
Search Engine Watch
October 16, 2008
Erik Qualman |
Obama is Winning the Internet War Election Day in the U.S. is fast approaching and it's anyone's guess who will win... or is it? Based on five key indicators on the Internet, maybe we already know who will next be sitting in the Oval Office. A look at these indicators shows how they can be applied to your business. |
Pharmaceutical Executive
January 1, 2013
Jill Wechsler |
Transformation to Characterize 2013 FDA policies will reshape drug development, while pressure to cut healthcare spending may alter drug coverage and pricing. |
The Motley Fool
February 27, 2009
Brian Orelli |
Can $634 Billion Save the U.S. Health Care System? The good news is that Obama's budget includes a $634 billion down payment on getting insurance for the 48 million uninsured. The bad news is that the president has to pay for that by cutting costs in other areas. |
Pharmaceutical Executive
December 1, 2008
Patrick Clinton |
Reason to Believe Here are a few things to be optimistic about in the pharmaceutical industry. |
The Motley Fool
July 29, 2008
Tristan Heinrich |
Could the Election Ruin Your Investments? How can you prepare your portfolio for the coming administration? Read on for ideas. |
Popular Mechanics
August 25, 2008 |
Obama, McCain Scout High-Tech Homeland Revamp Here is a breakdown of each candidate's positions on homeland security. |
Pharmaceutical Executive
April 1, 2011 |
How US Health Reform Is Hitting Canada Canada's Russell Williams, of Rx&D, talks about the impact of US health reform on his role as chief spokesman for the country's R&D industry. |
Pharmaceutical Executive
January 1, 2014
Jill Wechsler |
Pharma Challenges for 2014 Pricing and personalized medicine are key themes shaping drug development and marketing |
BusinessWeek
May 20, 2009
Maria Bartiromo |
Pfizer's Kindler on Health-Care Reform and the Wyeth Deal Pfizer's CEO discusses its acquisition of Wyeth and its plan to provide some drugs for free to those without jobs and insurance. |
Chemistry World
January 20, 2010
Phil Taylor |
Screw tightens on pay-for-delay drug deals Scrutiny of the tactics used by pharmaceutical companies to delay the entry of generics onto the market is rising on both sides of the Atlantic amid claims that the practice is costing consumers billions every year. |
Searcher
October 2010
Stephanie C. Ardito |
The Medical Digital: U.S. Healthcare Reform: A Follow-Up For those interested in serious, scholarly research regarding the historical progress of U.S. healthcare reform, this column and my prior column might be a good pairing for neutral sources. |
Salon.com
October 21, 2000
Jake Tapper |
McCain's awkward embrace of Bush Preparing to stump for the Texas governor, he becomes sick to his stomach -- as do some of his supporters... |
Popular Mechanics
September 25, 2008
Elizabeth Svoboda |
After River Pact's Backfire, McCain Counters Obama on Water When Sen. John McCain suggested renegotiating a key water conservation agreement last month, the ensuing political firestorm reminded voters just how important other "green" topics have become. |
Pharmaceutical Executive
January 1, 2012
Jill Wechsler |
New Year, New Issues Look for action in 2012 on drug access, shortages, innovation, and transparency. The 800-pound gorilla in the room is the looming Supreme Court decision on the constitutionality of the Obama health reform legislation. |
Pharmaceutical Executive
April 1, 2007
Porth & Sillup |
Media Audit: Stop the Presses! The media are becoming more negative and one-sided when it comes to reporting pharmaceutical industry news. |
Pharmaceutical Executive
February 1, 2011
Jon Zifferblat |
China: Business as UNusual If there is one market that requires a click on the 'refresh' button, it's China. General Biologic provides a snapshot of what's ahead for Big Pharma in the country |
On Wall Street
October 1, 2008
Donna Mitchell |
Sizing Up the Candidates on Major Money Issues If you let your wallet do your voting you have a month to decide which candidate will hurt you the least. |
Pharmaceutical Executive
December 1, 2010
Zhu Shen |
China 2020: Walled In No More Pharma sets the pace for China's ambitious new innovation agenda |
The Motley Fool
March 22, 2010
Brian Orelli |
Health-Care Reform Passes! Here's Where to Invest Now Some healthy suggestions for your portfolio. |
